Last reviewed · How we verify
NCT03636464: RRTdose
Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies
trial testing Blood collection in Renal Replacement Therapy in 200 participants. Currently enrolling.
1 July 2025
Quick facts
| Lead sponsor | Cleveland Clinic Abu Dhabi |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 April 2018 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across United Arab Emirates |
Drugs / interventions tested
- Blood collection — full drug profile →
Conditions studied
- Renal Replacement Therapy — all drugs for Renal Replacement Therapy →
Sponsor
Cleveland Clinic Abu Dhabi
Who can join
18 and older, any sex, with Renal Replacement Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aiming to describe the pharmacokinetic and pharmacodynamic profile of intravenous meropenem, ertapenem, cefepime, colistin, Ceftazidime/Avibactam , Ceftolozane/Tazobactam , and piperacillin/tazobactam in the plasma and determine how much is removed by Renal Replacement Therapies to ensure adequate dosing
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03636464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood collection
Trials testing the same drug.
- NCT07134491 — Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, · recruiting
- NCT07075107 — Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases · NA · not yet recruiting
- NCT06510868 — Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy · recruiting
- NCT06521502 — The APS Phenotyping Study · recruiting
- NCT06373510 — Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration · NA · not yet recruiting
Other recruiting trials for Renal Replacement Therapy
Currently open trials in the same condition.
- NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
- NCT06685367 — The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI) · NA · recruiting
- NCT06038162 — Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients · NA · recruiting
- NCT04705896 — Albumin To Enhance Recovery After Acute Kidney Injury · Phase 4 · recruiting
- NCT03329313 — Effects of Variation of Sodium Dialysate in ICU · Phase 2 · recruiting
Other Cleveland Clinic Abu Dhabi trials
Trials by the same sponsor.
- NCT05267782 — Correlation Between New O3 Regional Oximetry, Electroencephalography and the Somatosensory Evoked Potential in Carotid E · unknown
- NCT03947060 — The Alternative Position for the SedLine® Sensor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03636464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cleveland Clinic Abu Dhabi
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03636464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing